Allspring Global Investments Holdings, LLC Amylyx Pharmaceuticals, Inc. Transaction History

Allspring Global Investments Holdings, LLC

$59.3 Billion
Q4 2024

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 26, 2024	BUY	$1.62 - $2.71 $21,884 - $36,609	13,509 Added 88.43%	28,785 $54,000
Q1 2024 Apr 18, 2024	BUY	$2.71 - $19.57 $41,319 - $298,383	15,247 Added 52575.86%	15,276 $43,000
Q4 2023 Jan 25, 2024	SELL	$12.07 - $18.46 $170,887 - $261,356	-14,158 Reduced 99.8%	29 $0
Q3 2023 Oct 27, 2023	BUY	$18.08 - $23.45 $256,500 - $332,685	14,187 New	14,187 $259,000
Q2 2023 Jul 18, 2023	SELL	$20.98 - $31.42 $5.48 Million - $8.2 Million	-260,994 Reduced 93.95%	16,794 $362,000
Q1 2023 Apr 13, 2023	BUY	$27.71 - $40.93 $326,118 - $481,705	11,769 Added 4.42%	277,788 $8.15 Million
Q4 2022 Jan 23, 2023	SELL	$29.75 - $39.26 $103,500 - $136,585	-3,479 Reduced 1.29%	266,019 $0
Q3 2022 Oct 26, 2022	SELL	$17.15 - $30.92 $2.5 Million - $4.51 Million	-145,800 Reduced 35.11%	269,498 $7.59 Million
Q2 2022 Jul 25, 2022	BUY	$6.85 - $19.93 $88,871 - $258,571	12,974 Added 3.22%	415,298 $8 Million
Q1 2022 May 02, 2022	BUY	$12.85 - $32.9 $5.17 Million - $13.2 Million	402,324 New	402,324 $5.17 Million

Others Institutions Holding AMLX

# of Institutions

128

Shares Held

44M

Call Options Held

235K

Put Options Held

530K

Tcg Crossover Management, LLC Palo Alto, CA

4.64M
Shares

$17.9 Million
1.95% of portfolio
Vanguard Group Inc Valley Forge, PA

3.09M
Shares

$11.9 Million
0.0% of portfolio
Black Rock Inc. New York, NY

2.67M
Shares

$10.3 Million
0.0% of portfolio
Perceptive Advisors LLC New York, NY

2.13M
Shares

$8.18 Million
0.18% of portfolio
Alyeska Investment Group, L.P. Chicago, IL

2.02M
Shares

$7.79 Million
0.04% of portfolio

View Full List

About Amylyx Pharmaceuticals, Inc.

Ticker AMLX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 58,533,200
Market Cap $225M
Description
Amylyx Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, engages in developing various therapeutics for amyotrophic lateral sclerosis (ALS) and other neurodegenerative diseases. The company's product pipeline includes AMX0035, a dual UPR-Bax apoptosis inhibitor composed of sodium phenylbutyrate and taurursodiol for the treatment...

More about AMLX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Allspring Global Investments Holdings, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Allspring Global Investments Holdings, LLC with notifications on news.

Account